Navigation

Investiment.io
Financial analysis platform

Eli Lilly and Company

LLY โ€ข NYSE

$1,431.67
โ–ผ11.83 (0.82%)โ€ข REGULAR

Eli Lilly and Company

$1,431.67
โ–ผ0.8%
๐Ÿ“ŠSummary๐Ÿ“‹SEC Filings๐Ÿ‘ฅInsider Trading
โš–๏ธ

Balance SheetLLY

Balance Sheet Summary

Key balance sheet metrics and financial position for LLY

๐Ÿข
Total Assets
$112,476,000
(in thousands USD)
๐Ÿ“‹
Total Liabilities
N/A
(in thousands USD)
๐Ÿ‘ฅ
Shareholders' Equity
$26,535,000
(in thousands USD)
โš–๏ธ
Debt-to-Equity Ratio
1.54
Long-term Debt / Equity

Balance Sheet Analysis

Analyze assets, liabilities, and equity trends over time

Period:annual

Select Metrics to Compare (4 selected)

Total Assets Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$30.00B$60.00B$90.00B$120.00B0%+15%+30%+45%+60%
  • Total Assets
  • Total Assets YoY Growth

Total Liabilities Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$1.00K$2.00K$3.00K$4.00K
  • Total Liabilities
  • Total Liabilities YoY Growth

Total Shareholders' Equity Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025$0.00K$7.00B$14.00B$21.00B$28.00B0%+25%+50%+75%+100%
  • Total Shareholders' Equity
  • Total Shareholders' Equity YoY Growth

Cash and Cash Equivalents Trend & Growth

Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 20250.002000000000.004000000000.006000000000.008000000000.00-50%0%+50%+100%+150%
  • Cash and Cash Equivalents
  • Cash and Cash Equivalents YoY Growth